Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure. (Q45919565)

17 December 2017

title

Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure. (English)

1 reference

17 December 2017

1 reference

Julian C Braz

1

1 reference

17 December 2017

Robert M Gill

2

1 reference

17 December 2017

Angela K Corbly

3

1 reference

17 December 2017

Bonita D Jones

4

1 reference

17 December 2017

Najia Jin

5

1 reference

17 December 2017

Chris J Vlahos

6

1 reference

17 December 2017

Qingyu Wu

7

1 reference

17 December 2017

Weiqun Shen

8

1 reference

17 December 2017

publication date

1 August 2009

1 reference

17 December 2017

European Journal of Heart Failure

published in

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

739-748

1 reference

17 December 2017

Signalling through the lipid products of phosphoinositide-3-OH kinase

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

The conserved phosphoinositide 3-kinase pathway determines heart size in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Akt/protein kinase B promotes organ growth in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Inhibition of glycogen synthase kinase 3beta during heart failure is protective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Protein kinase cascades in the regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Role of phosphoinositide 3-kinase in cardiac function and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP094

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFP094

1 reference

17 December 2017

1 reference

17 December 2017